Dr. Syn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1008 South Spring Avenue
SLUCare Academic Pavilion, 2nd Floor
Saint Louis, MO 63110Phone+1 314-977-2171
Education & Training
- University of Sheffield School of MedicineClass of 1998
Certifications & Licensure
- MO State Medical License 2021 - 2024
- SC State Medical License 2015 - 2022
Clinical Trials
- Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2016 Mar 01
- Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension Start of enrollment: 2016 Oct 17
- Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis Start of enrollment: 2017 Aug 30
Publications & Presentations
PubMed
- 61 citationsHuman intrahepatic regulatory T cells are functional, require IL‐2 from effector cells for survival, and are susceptible to Fas ligand‐mediated apoptosisYung-Yi Chen, Hannah C. Jeffery, Stuart Hunter, Ricky H. Bhogal, Jane Birtwistle
Hepatology. 2016-07-01 - 122 citationsHedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.George Philips, Isaac S. Chan, Marzena Swiderska, Vanessa T. Schroder, Cynthia D. Guy
Plos One. 2011-09-02 - 284 citationsHedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humansAlessia Omenetti, Alessandro Porrello, Youngmi Jung, Liu Yang, Yury Popov
The Journal of Clinical Investigation. 2008-10-01
Committees
- NASH Council Member, Global Liver Institute 2018 - Present
- Committee Member, National VA NAFLD Strategic Planning Committee 2019 - 2021
- Education Steering Committee, AASLD Liver Fibrosis SIG 2018 - 2020
- Member, RHJ VAMC R&D Committee 2016 - 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: